Cargando…
A chimeric MERS-CoV virus-like particle vaccine protects mice against MERS-CoV challenge
BACKGROUND: Middle East respiratory syndrome coronavirus (MERS-CoV) causes severe respiratory disease in humans, with a case fatality rate of approximately 35%, thus posing a considerable threat to public health. The lack of approved vaccines or antivirals currently constitutes a barrier in controll...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235161/ https://www.ncbi.nlm.nih.gov/pubmed/35761402 http://dx.doi.org/10.1186/s12985-022-01844-9 |